Rep. April McClain Delaney Purchases Shares of BWX Technologies, Inc. (NYSE:BWXT)

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of BWX Technologies, Inc. (NYSE:BWXT). In a filing disclosed on August 03rd, the Representative disclosed that they had bought between $15,001 and $50,000 in BWX Technologies stock on July 24th.

Representative April McClain Delaney also recently made the following trade(s):

  • Purchased $15,001 – $50,000 in shares of Life Time Group (NYSE:LTH) on 7/31/2026.
  • Purchased $15,001 – $50,000 in shares of Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) on 7/31/2026.
  • Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/31/2026.
  • Purchased $15,001 – $50,000 in shares of C.H. Robinson Worldwide (NASDAQ:CHRW) on 7/31/2026.
  • Sold $1,001 – $15,000 in shares of STERIS (NYSE:STE) on 7/31/2026.
  • Purchased $15,001 – $50,000 in shares of Somnigroup International (NYSE:SGI) on 7/30/2026.
  • Purchased $1,001 – $15,000 in shares of Entegris (NASDAQ:ENTG) on 7/30/2026.
  • Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/30/2026.
  • Purchased $1,001 – $15,000 in shares of Life Time Group (NYSE:LTH) on 7/30/2026.
  • Sold $1,001 – $15,000 in shares of Service Corporation International (NYSE:SCI) on 7/30/2026.

BWX Technologies Price Performance

BWX Technologies stock opened at $168.65 on Thursday. The stock’s 50 day moving average is $186.21 and its 200 day moving average is $200.99. BWX Technologies, Inc. has a one year low of $157.10 and a one year high of $241.82. The firm has a market cap of $15.45 billion, a P/E ratio of 43.69, a P/E/G ratio of 2.85 and a beta of 0.76. The company has a debt-to-equity ratio of 1.51, a current ratio of 2.40 and a quick ratio of 2.33.

BWX Technologies (NYSE:BWXTGet Free Report) last released its earnings results on Monday, August 3rd. The technology company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.03. BWX Technologies had a net margin of 10.11% and a return on equity of 30.83%. The business had revenue of $901.62 million during the quarter, compared to the consensus estimate of $902.41 million. During the same quarter in the prior year, the firm posted $1.02 EPS. The company’s revenue for the quarter was up 18.0% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. As a group, research analysts expect that BWX Technologies, Inc. will post 4.74 EPS for the current year.

BWX Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Tuesday, August 18th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, August 18th. BWX Technologies’s payout ratio is currently 27.98%.

Key Headlines Impacting BWX Technologies

Here are the key news stories impacting BWX Technologies this week:

  • Positive Sentiment: BWXT agreed to sell its medical isotopes business to Nordic Capital for up to $800 million. The divestiture should provide liquidity for investment in nuclear-energy, small modular reactor and defense capacity, while allowing the company to focus on its core businesses. BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
  • Positive Sentiment: Second-quarter results exceeded expectations, with adjusted EPS of $1.07 versus the $1.04 consensus and revenue of approximately $901.6 million, up 18% year over year. Commercial operations revenue increased 72% to $302.5 million, while backlog expanded to roughly $8.39 billion. BWXT Q2 Earnings Call Centers on Higher Outlook and Nuclear Focus
  • Positive Sentiment: Management raised 2026 adjusted EPS guidance to $4.70–$4.80 and free-cash-flow guidance to $345 million–$360 million. The company also recently completed its Precision Components Group acquisition, expanding manufacturing capabilities for commercial nuclear components. BWXT Raises EPS and Free Cash Flow Outlook
  • Positive Sentiment: BTIG reaffirmed its Buy rating and maintained a $235 price target. Northland Securities modestly increased its FY2026 EPS estimate to $4.71 and FY2027 estimate to $5.17, signaling confidence in longer-term earnings growth.
  • Neutral Sentiment: BWXT maintained its quarterly dividend at $0.27 per share, payable September 4, although the approximately 0.6% yield is unlikely to be a major near-term share-price catalyst.
  • Negative Sentiment: Northland lowered its Q3 2026 EPS estimate to $1.18 from $1.22, potentially contributing to pressure on near-term earnings expectations. BWXT also trades at a relatively high valuation, while regulatory delays, long SMR deployment timelines and integration or capacity-expansion costs remain risks.

Analysts Set New Price Targets

Several research firms have recently weighed in on BWXT. Wall Street Zen upgraded shares of BWX Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Truist Financial upped their price target on shares of BWX Technologies from $205.00 to $212.00 and gave the company a “hold” rating in a research report on Monday, May 11th. Zacks Research downgraded BWX Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Seaport Research Partners raised BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price objective for the company in a research report on Monday, June 22nd. Finally, BTIG Research reissued a “buy” rating and issued a $235.00 price objective on shares of BWX Technologies in a research note on Tuesday. Two research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, BWX Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $228.20.

Check Out Our Latest Report on BWXT

Insider Buying and Selling at BWX Technologies

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the sale, the chief executive officer directly owned 202,491 shares of the company’s stock, valued at approximately $41,472,181.71. The trade was a 4.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $209.25, for a total transaction of $505,757.25. Following the transaction, the chief financial officer owned 6,884 shares in the company, valued at $1,440,477. This represents a 25.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company’s stock.

Institutional Trading of BWX Technologies

Large investors have recently modified their holdings of the stock. Pecaut & CO. bought a new stake in shares of BWX Technologies in the 2nd quarter valued at $1,545,000. Oppenheimer Asset Management Inc. bought a new position in BWX Technologies during the second quarter worth $1,233,000. Insight Wealth Strategies LLC bought a new position in BWX Technologies during the second quarter worth $5,949,000. Tema ETFs LLC grew its holdings in BWX Technologies by 45.5% in the second quarter. Tema ETFs LLC now owns 81,179 shares of the technology company’s stock worth $15,801,000 after purchasing an additional 25,368 shares during the period. Finally, Fulton Bank N.A. grew its holdings in BWX Technologies by 3.6% in the second quarter. Fulton Bank N.A. now owns 6,186 shares of the technology company’s stock worth $1,204,000 after purchasing an additional 213 shares during the period. Institutional investors and hedge funds own 94.39% of the company’s stock.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About BWX Technologies

(Get Free Report)

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.

Read More

Receive News & Ratings for BWX Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BWX Technologies and related companies with MarketBeat.com's FREE daily email newsletter.